Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene (APOL1)

计划入组 88 人 · 首次发布于 2025 年 12 月 17 日

APOL1 Genetic Testing Program for Living Donors

计划入组 280 人 · 首次发布于 2021 年 6 月 2 日

Apolipoprotein E (ApoE) and Metabolism

计划入组 100 人 · 首次发布于 2017 年 4 月 12 日

Human papillomavirus type 16 L1 capsid protein antigen(Cervarix, Gardasil, Gardasil 9)

Human papillomavirus type 6 L1 capsid protein antigen(Gardasil, Gardasil 9)

Human papillomavirus type 18 L1 capsid protein antigen(Cervarix, Gardasil, Gardasil 9)

3D MEDICINES

Hong Kong, China

Maze Therapeutics' MZE829 Shows Promise in Phase I Trial for APOL1 Kidney Disease

Maze Therapeutics Initiates Phase 2 Trial of MZE829 for APOL1 Kidney Disease

ApoA-I Infusions Show Promise in Reducing Cardiovascular Events Post-MI, Especially in Patients with Lower LDL-C